Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Is HPV-18 present in human breast cancer cell lines?

Peran I, Riegel A, Dai Y, Schlegel R, Liu X.

Br J Cancer. 2010 May 11;102(10):1549-50; author reply 1551-2. doi: 10.1038/sj.bjc.6605671. Epub 2010 Apr 20. No abstract available.

2.

No evidence for an association of human papillomavirus and breast carcinoma.

Silva RG Jr, da Silva BB.

Breast Cancer Res Treat. 2011 Jan;125(1):261-4. doi: 10.1007/s10549-010-1129-z. Epub 2010 Aug 24.

PMID:
20734131
3.

Human papillomavirus is associated with breast cancer in the north part of Iran.

Sigaroodi A, Nadji SA, Naghshvar F, Nategh R, Emami H, Velayati AA.

ScientificWorldJournal. 2012;2012:837191. doi: 10.1100/2012/837191. Epub 2012 Apr 1.

4.

Low frequency of human papillomavirus DNA in breast cancer tissue.

Mendizabal-Ruiz AP, Morales JA, Ramírez-Jirano LJ, Padilla-Rosas M, Morán-Moguel MC, Montoya-Fuentes H.

Breast Cancer Res Treat. 2009 Mar;114(1):189-94. doi: 10.1007/s10549-008-9989-1. Epub 2008 Mar 30.

PMID:
18373273
5.

Limited evidence of human papillomavirus in [corrected] breast tissue using molecular in situ methods.

Baltzell K, Buehring GC, Krishnamurthy S, Kuerer H, Shen HM, Sison JD.

Cancer. 2012 Mar 1;118(5):1212-20. doi: 10.1002/cncr.26389. Epub 2011 Aug 5. Erratum in: Cancer. 2012 May 1;118(9):2561.

6.

Impact of sampling origin on molecular detection of high-risk human papillomavirus and oncogene expression.

Kahla S, Achour M, Oueslati S, Kochbati L, Chanoufi MB, Maalej M, Oueslati R.

Eur J Gynaecol Oncol. 2012;33(2):187-92.

PMID:
22611961
7.

Comparison between the Abbott RealTime High Risk HPV assay and the Hybrid Capture 2 assay for detecting high-risk human papillomavirus DNA in cervical specimens.

Kaliterna V, Lepej SZ, Vince A.

J Med Microbiol. 2009 Dec;58(Pt 12):1662-3. doi: 10.1099/jmm.0.012138-0. Epub 2009 Aug 6. No abstract available.

PMID:
19661205
8.

Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer.

Kailash U, Soundararajan CC, Lakshmy R, Arora R, Vivekanandhan S, Das BC.

Br J Cancer. 2006 Nov 6;95(9):1250-7. Epub 2006 Oct 24.

9.

HPV infection and breast cancer.

Damin AP, Damin DC, Alexandre CO.

Breast. 2007 Jun;16(3):222. Epub 2007 Mar 29. No abstract available.

PMID:
17398094
10.

Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16, -18 and -58 in esophageal and cervical cancer: a case-control study.

Zhang D, Zhang Q, Zhou L, Huo L, Zhang Y, Shen Z, Zhu Y.

BMC Cancer. 2010 Nov 26;10:650. doi: 10.1186/1471-2407-10-650.

11.

Human papillomavirus (HPV) in breast tumors: prevalence in a group of Mexican patients.

de León DC, Montiel DP, Nemcova J, Mykyskova I, Turcios E, Villavicencio V, Cetina L, Coronel A, Hes O.

BMC Cancer. 2009 Jan 22;9:26. doi: 10.1186/1471-2407-9-26.

12.

[Enhanced molecular techniques for the diagnosis of human papillomavirus infections].

Ursu RG, Onofriescu M, Nemescu D, Iancu LS.

Rev Med Chir Soc Med Nat Iasi. 2009 Oct-Dec;113(4):1205-10. Romanian.

PMID:
20191900
13.

Real-time duplex PCR for simultaneous HPV 16 and HPV 18 DNA quantitation.

Jacquin E, Saunier M, Mauny F, Schwarz E, Mougin C, Prétet JL.

J Virol Methods. 2013 Nov;193(2):498-502. doi: 10.1016/j.jviromet.2013.07.023. Epub 2013 Jul 24.

PMID:
23891872
14.

Lymphoepithelioma-like carcinoma of the breast: not Epstein-Barr virus-, but human papilloma virus-positive.

Kulka J, Kovalszky I, Svastics E, Berta M, Füle T.

Hum Pathol. 2008 Feb;39(2):298-301. doi: 10.1016/j.humpath.2007.08.006.

PMID:
18206498
15.

High-risk human papillomavirus (HPV) DNA sequences in metaplastic breast carcinomas of Mexican women.

Herrera-Goepfert R, Vela-Chávez T, Carrillo-García A, Lizano-Soberón M, Amador-Molina A, Oñate-Ocaña LF, Hallmann RS.

BMC Cancer. 2013 Oct 1;13:445. doi: 10.1186/1471-2407-13-445.

16.

Distribution of HPV genotypes in women with cervical cancer in Auckland, New Zealand; a review of 50 specimens between 2000-2006.

Williamson D, Nagappan R, Sirikonda R, Rahnama F, Thomas S, Lovell-Smith M, Croxson M.

Aust N Z J Obstet Gynaecol. 2011 Feb;51(1):67-70. doi: 10.1111/j.1479-828X.2010.01251.x. Epub 2010 Dec 7.

PMID:
21299512
17.

Prevalence of high-risk human papillomavirus by cobas 4800 HPV test in urban Peru.

Iwasaki R, Galvez-Philpott F, Arias-Stella J Jr, Arias-Stella J.

Braz J Infect Dis. 2014 Sep-Oct;18(5):469-72. doi: 10.1016/j.bjid.2014.01.010. Epub 2014 May 15.

18.

Laboratory-developed L1 sequencing and type-specific, real-time polymerase chain reaction for the detection and typing of human papillomaviruses in formalin-fixed, paraffin-embedded tissues.

Mills A, Balasubramaniam R, Longacre TA, Kong CS, Pinsky BA.

Arch Pathol Lab Med. 2013 Jan;137(1):50-4. doi: 10.5858/arpa.2011-0392-OA.

PMID:
23276174
19.

Integration of human papillomavirus 18 DNA in esophageal carcinoma 109 cells.

Zhang K, Li JT, Li SY, Zhu LH, Zhou L, Zeng Y.

World J Gastroenterol. 2011 Oct 7;17(37):4242-6. doi: 10.3748/wjg.v17.i37.4242.

20.

Evaluation of E6 and E7 mRNA expression in HPV DNA positive breast cancer.

Frega A, Lorenzon L, Bononi M, De Cesare A, Ciardi A, Lombardi D, Assorgi C, Gentile M, Moscarini M, Torrisi MR, French D.

Eur J Gynaecol Oncol. 2012;33(2):164-7.

PMID:
22611956

Supplemental Content

Support Center